<SEC-DOCUMENT>0001171843-21-001304.txt : 20210225
<SEC-HEADER>0001171843-21-001304.hdr.sgml : 20210225
<ACCEPTANCE-DATETIME>20210225070556
ACCESSION NUMBER:		0001171843-21-001304
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20210225
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210225
DATE AS OF CHANGE:		20210225

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOCRYST PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000882796
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				621413174
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-23186
		FILM NUMBER:		21676366

	BUSINESS ADDRESS:	
		STREET 1:		4505 EMPEROR BOULEVARD
		STREET 2:		SUITE 200
		CITY:			DURHAM
		STATE:			NC
		ZIP:			27703
		BUSINESS PHONE:		919-859-1302

	MAIL ADDRESS:	
		STREET 1:		4505 EMPEROR BOULEVARD
		STREET 2:		SUITE 200
		CITY:			DURHAM
		STATE:			NC
		ZIP:			27703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8k_022521.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:us-roles="http://fasb.org/us-roles/2019-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31"><head><title>Form 8-K</title></head><body style="font-size: 10pt"><div style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="Form8K">0000882796</ix:nonNumeric> <ix:nonNumeric format="ixt:booleanfalse" name="dei:AmendmentFlag" contextRef="Form8K">False</ix:nonNumeric></ix:hidden><ix:references> <link:schemaRef xlink:href="gnw-20190101.xsd" xlink:type="simple"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="Form8K"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000882796</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-25</xbrli:startDate> <xbrli:endDate>2021-02-25</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:unit id="USD"> <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unit> <xbrli:unit id="Shares"> <xbrli:measure>xbrli:shares</xbrli:measure> </xbrli:unit> <xbrli:unit id="USDPShares"> <xbrli:divide> <xbrli:unitNumerator> <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unitNumerator> <xbrli:unitDenominator> <xbrli:measure>xbrli:shares</xbrli:measure> </xbrli:unitDenominator> </xbrli:divide> </xbrli:unit> </ix:resources></ix:header></div><div style="margin-top: 3pt; margin-bottom: 12pt;"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%;">&#160;</div></div><p style="font-size: 14pt; font-weight: bold; text-align: center; margin-top: 6pt; margin-bottom: 0pt;">UNITED STATES</p><p style="font-size: 14pt; font-weight: bold; text-align: center; margin-top: 0pt; margin-bottom: 0pt;">SECURITIES AND EXCHANGE COMMISSION</p><p style="font-size: 14pt; font-weight: bold; text-align: center; margin-top: 0pt; margin-bottom: 6pt;">Washington, D.C. 20549</p><p style="text-align: center;">_________________</p><p style="font-size: 14pt; font-weight: bold; text-align: center; margin-top: 6pt; margin-bottom: 6pt;">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="Form8K">8-K</ix:nonNumeric></p><p style="text-align: center;">_________________</p><p style="font-size: 12pt; font-weight: bold; text-align: center; margin-top: 6pt; margin-bottom: 6pt;">CURRENT REPORT</p><p style="font-size: 12pt; font-weight: bold; text-align: center; margin-top: 6pt; margin-bottom: 6pt;">Pursuant to Section 13 or 15(d)<br />of the Securities Exchange Act of 1934</p><p style="font-size: 10pt; font-weight: bold; text-align: center; margin-top: 6pt; margin-bottom: 6pt;">Date of Report (Date of earliest event reported):&#160; <ix:nonNumeric format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" contextRef="Form8K">February 25, 2021</ix:nonNumeric></p><p style="text-align: center;">_______________________________</p><p style="font-size: 12pt; text-align: center; margin-top: 6pt; margin-bottom: 0; font-weight: bold; text-transform: uppercase;"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="Form8K">BioCryst Pharmaceuticals, Inc.</ix:nonNumeric></p><p style="font-size: 10pt; text-align: center; margin-top: 0; margin-bottom: 6pt;">(Exact name of registrant as specified in its charter)</p><p style="text-align: center;">_______________________________</p><table style="width: 100%; margin-right: auto; margin-left: auto;" border="0" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 33%; font-size: 10pt; font-weight: bold; text-align: center;"><ix:nonNumeric format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" contextRef="Form8K">Delaware</ix:nonNumeric></td><td style="width: 34%; font-size: 10pt; text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="Form8K">000-23186</ix:nonNumeric></td><td style="width: 33%; font-size: 10pt; font-weight: bold; text-align: center;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="Form8K">62-1413174</ix:nonNumeric></td></tr><tr style="vertical-align: top;"><td style="font-size: 10pt; text-align: center;">(State or Other Jurisdiction of Incorporation)</td><td style="font-size: 10pt; text-align: center;">(Commission File Number)</td><td style="font-size: 10pt; text-align: center;">(I.R.S. Employer Identification No.)</td></tr></table><!-- Postal Address Country= --><p style="font-size: 10pt; text-align: center; margin-top: 12pt; margin-bottom: 0pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="Form8K">4505 Emperor Blvd., Suite 200</ix:nonNumeric></p><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="Form8K">Durham</ix:nonNumeric>, <ix:nonNumeric format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" contextRef="Form8K">North Carolina</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="Form8K">27703</ix:nonNumeric></p><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 6pt;">(Address of Principal Executive Offices) (Zip Code)</p><!-- Phone Number --><p style="font-size: 10pt; font-weight: bold; text-align: center; margin-top: 0pt; margin-bottom: 0pt;">(<ix:nonNumeric name="dei:CityAreaCode" contextRef="Form8K">919</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="Form8K">859-1302</ix:nonNumeric></p><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 6pt;">(Registrant's telephone number, including area code)</p><!-- Former Name --><p style="font-size: 10pt; font-weight: bold; text-align: center; margin-top: 0pt; margin-bottom: 0pt;">&#160;</p><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt;">(Former name or former address, if changed since last report)</p><p style="text-align: center;">_______________________________</p><!-- Checkboxes --><p style="font-size: 10pt; text-align: left; text-indent: 0; margin-top: 6pt; margin-bottom: 6pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p><table style="width: 100%; margin-top: 6pt; margin-bottom: 6pt; font-size: 10pt;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 3%; text-align: center; vertical-align: middle;"><ix:nonNumeric format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" contextRef="Form8K">&#9744;</ix:nonNumeric></td><td style="width: 97%; text-align: left;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr><tr style="vertical-align: top;"><td style="width: 3%; text-align: center; vertical-align: middle;"><ix:nonNumeric format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" contextRef="Form8K">&#9744;</ix:nonNumeric></td><td style="width: 97%; text-align: left;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr><tr style="vertical-align: top;"><td style="width: 3%; text-align: center; vertical-align: middle;"><ix:nonNumeric format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" contextRef="Form8K">&#9744;</ix:nonNumeric></td><td style="width: 97%; text-align: left;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td></tr><tr style="vertical-align: top;"><td style="width: 3%; text-align: center; vertical-align: middle;"><ix:nonNumeric format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" contextRef="Form8K">&#9744;</ix:nonNumeric></td><td style="width: 97%; text-align: left;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</td></tr></table><!-- Securities Table --><p style="font-size: 10pt; text-align: left; text-indent: 0; margin-top: 6pt; margin-bottom: 6pt;">Securities registered pursuant to Section 12(b) of the Act:</p><div><table border="0" cellspacing="0" cellpadding="0" style="width: 100%"><tr style="vertical-align: top"><td style="font-size: 10pt; text-align: center; margin-top: 6pt; margin-bottom: 6pt; width: 39%; border-bottom: Black 1pt solid">Title of each class</td><td style="font-size: 10pt; text-align: center; margin-top: 6pt; margin-bottom: 6pt; width: 23%; border-bottom: Black 1pt solid">Trading Symbol(s)</td><td style="font-size: 10pt; text-align: center; margin-top: 6pt; margin-bottom: 6pt; width: 38%; border-bottom: Black 1pt solid">Name of each exchange on which registered</td></tr><tr style="vertical-align: top"><td style="font-size: 10pt; text-align: center"><span><ix:nonNumeric contextRef="Form8K" name="dei:Security12bTitle">Common Stock</ix:nonNumeric></span></td><td style="font-size: 10pt; text-align: center"><span><ix:nonNumeric contextRef="Form8K" name="dei:TradingSymbol">BCRX</ix:nonNumeric></span></td><td style="font-size: 10pt; text-align: center"><span><ix:nonNumeric contextRef="Form8K" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><!-- Emerging Growth Company --><p style="font-size: 10pt; text-align: left; text-indent: 0; margin-top: 6pt; margin-bottom: 6pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p><p style="font-size: 10pt; text-align: left; text-indent: 0; margin-top: 6pt; margin-bottom: 6pt;">Emerging growth company <ix:nonNumeric format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" contextRef="Form8K">&#9744;</ix:nonNumeric></p><p style="font-size: 10pt; text-align: left; text-indent: 0; margin-top: 6pt; margin-bottom: 6pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: Black 4pt solid;">&#160;</div><div style="page-break-before: always; margin-top: 0pt; margin-bottom: 0pt;">&#160;</div><!-- 8-K Items --><div><div><div style="font-size: 10pt;"><strong>Item 2.02. Results of Operations and Financial Condition.</strong></div><div style="font-size: 10pt;"><p>On February 25, 2021, BioCryst Pharmaceuticals, Inc. (the "Company") issued a press release announcing recent corporate developments and its financial results for the fourth quarter and full year ended December 31, 2020, which also referenced a conference call and webcast to discuss these recent corporate developments and financial results. A copy of the press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.</p></div></div><div><div style="font-size: 10pt;"><strong>Item 7.01. Regulation FD Disclosure.</strong></div><div style="font-size: 10pt;"><p>The information furnished on Exhibit 99.1 is incorporated by reference under this Item 7.01 as if fully set forth herein.</p><p>The information in this Current Report on Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.</p></div></div><div><div style="font-size: 10pt;"><strong>Item 9.01. Financial Statements and Exhibits.</strong></div><div style="font-size: 10pt;"><p>(d) Exhibits</p><table style="font-size: 10pt;" border="0" cellspacing="0" cellpadding="0"><tr><td style="font-size: 10pt; font-weight: bold; text-decoration-line: underline;" valign="bottom">Exhibit No.</td><td style="font-size: 10pt; width: 20px;">&#160;</td><td style="font-size: 10pt; font-weight: bold; text-decoration-line: underline;" valign="bottom">Description</td></tr><tr><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; width: 20px;">&#160;</td><td style="font-size: 10pt;">&#160;</td></tr><tr><td style="font-size: 10pt;"><a href="exh_991.htm">99.1</a></td><td style="font-size: 10pt; width: 20px;">&#160;</td><td style="font-size: 10pt;"><a href="exh_991.htm">Press release dated February 25, 2021 entitled "BioCryst Reports Fourth Quarter and Full Year 2020 Financial Results and Upcoming Key Milestones"</a></td></tr><tr><td style="font-size: 10pt;">104</td><td style="font-size: 10pt; width: 20px;">&#160;</td><td style="font-size: 10pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr></table></div></div></div><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: Black 4pt solid;">&#160;</div><div style="page-break-before: always; margin-top: 0pt; margin-bottom: 0pt;">&#160;</div><!-- Signatures --><p style="font-size: 10pt; text-align: center; font-weight: bold;">SIGNATURE</p><p style="font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><table style="width: 100%;" border="0" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td>&#160;</td><td style="font-size: 10pt; font-weight: bold;" colspan="2">BioCryst Pharmaceuticals, Inc.</td></tr><tr style="vertical-align: top;"><td style="width: 49%;">&#160;</td><td style="width: 2%;">&#160;</td><td style="width: 49%;">&#160;</td></tr><tr style="vertical-align: top;"><td>&#160;</td><td>&#160;</td><td style="font-size: 10pt;"></td></tr><tr style="vertical-align: top;"><td style="font-size: 10pt;">Date: February 25, 2021</td><td style="font-size: 10pt;">By:&#160;</td><td style="text-decoration: underline; font-size: 10pt;">/s/ Alane Barnes&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td></tr><tr style="vertical-align: top;"><td>&#160;</td><td>&#160;</td><td style="font-size: 10pt;">Alane Barnes</td></tr><tr style="vertical-align: top;"><td>&#160;</td><td>&#160;</td><td style="font-size: 10pt;">Senior Vice President and Chief Legal Officer</td></tr><tr style="vertical-align: top;"><td>&#160;</td><td>&#160;</td><td style="font-size: 10pt;"></td></tr></table><!-- Exhibit Index --><div></div><!-- (919) 859-1302 Form 8-KFebruary 25, 2021 --><p>&#160;</p></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exh_991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><html lang="en-US"><head><title>EdgarFiling</title><meta content="text/html; charset=windows-1252" ><meta name="GENERATOR" content="MSHTML 8.00.7601.18094" ></head><body bgcolor="#ffffff"><p style="text-align: right;"><strong>EXHIBIT 99.1</strong></p><p style="text-align: center;"><font style="font-size: 14pt;"><strong>BioCryst Reports Fourth Quarter and Full Year 2020 Financial Results and Upcoming Key Milestones</strong></font></p><p style="text-align: center;"><strong></strong></p><p>
 <p align="center"><strong><em>&#8212;ORLADEYO&#153; (berotralstat) now approved in U.S. and Japan; EU approval expected in Q2&#8212;</em></strong><br ></p>  <p align="center"><strong><em>&#8212;Dose-ranging trial of BCX9930 has fully enrolled 16 PNH patients; Data to be presented at R&amp;D day March 22 &#8212;</em></strong></p>  <p align="center"><strong><em>&#8212;Company adds $325 million in financing in Q4 2020; Year-end cash of $303 million provides cash runway into 2023&#8212;</em></strong>&#160;</p>  <p align="justify">RESEARCH TRIANGLE PARK, N.C., Feb.  25, 2021  (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced financial results for the fourth quarter and full year ended December 31, 2020, and provided a corporate update.</p>  <p align="justify">&#8220;With two approvals for ORLADEYO, our launch in the U.S., proof of concept data for BCX9930 in complement-mediated diseases, a successful phase 1 trial of BCX9250 for FOP and the addition of more than $425 million through our May and December financings, 2020 was a transformational year for BioCryst,&#8221; said Jon Stonehouse, president and chief executive officer of BioCryst.</p>  <p align="justify">&#8220;Using our strong balance sheet as a foundation, we expect to continue this transformation in 2021 with ORLADEYO generating revenue in the U.S., Japan and Europe, and the opportunity to significantly advance the 9930 program as an oral monotherapy for both PNH, and renal complement-mediated diseases,&#8221; Stonehouse added.</p>  <p align="justify"><strong>Program Updates and Key Milestones</strong></p>  <p align="justify"><strong><em>ORLADEYO&#153; (berotralstat): Oral, Once-daily Treatment for Prevention of Hereditary Angioedema&#160;</em></strong><strong><em>(HAE) Attacks</em></strong></p>  <ul type="disc"><li style="text-align:justify;">BioCryst launched ORLADEYO in the United States following U.S. Food and Drug Administration (FDA) approval on December 3, 2020, and product shipments began on December 16, 2020.<br ><br ></li><li style="text-align:justify;">On January 22, 2021, the company announced that the Ministry of Health, Labor and Welfare (MHLW) in Japan had granted marketing and manufacturing approval for oral, once-daily ORLADEYO 150 mg for prophylactic treatment of hereditary angioedema (HAE) in adults and pediatric patients 12 years and older. <br ><br > <ul type="circle"><li style="text-align:justify;">ORLADEYO is the first and only prophylactic HAE medication approved in Japan and will be commercialized in Japan by BioCryst&#8217;s partner, Torii Pharmaceutical Co., Ltd. OrphanPacific, Inc. is BioCryst&#8217;s representative partner in Japan and holds the marketing authorization. <br ><br ></li><li style="text-align:justify;">Torii will launch ORLADEYO in Japan following the successful completion of BioCryst&#8217;s pricing negotiations with the Japanese National Health Insurance System (NHI). <br ><br ></li><li style="text-align:justify;">BioCryst is eligible to receive an additional milestone payment of $15 million from Torii upon receipt of a reimbursement price from the NHI in excess of the threshold specified in the agreement with Torii. In addition, BioCryst will receive tiered royalties ranging from 20 percent to potentially 40 percent of Japanese net sales.</li></ul> </li></ul>  <ul type="disc"><li style="text-align:justify;">In Europe, the Committee for Medicinal Products for Human Use (CHMP) is scheduled to review the ORLADEYO marketing authorization application this week. The company expects approval from the European Commission (EC) approximately 60 days following a positive opinion from the CHMP.<br ><br > <ul type="circle"><li style="text-align:justify;">On October 30, 2020, the company announced that the United Kingdom&#8217;s Medicines and Healthcare products Regulatory Agency (MHRA) had granted ORLADEYO a positive scientific opinion through the Early Access to Medicines Scheme (EAMS). Under the EAMS, HAE patients in the UK aged 12 years and older can gain access to ORLADEYO for the routine prevention of recurrent attacks of HAE before the drug is granted marketing authorization by the EC. <br ><br ></li></ul> </li><li style="text-align:justify;">In the fourth quarter of 2020, the company presented data in several manuscripts and abstracts.<br ><br > <ul type="circle"><li style="text-align:justify;">On October 22, 2020, the company announced that data from the first 24 weeks of the Phase 3 APeX-2 trial of ORLADEYO in 121 HAE patients ages 12 years or older had been published online by the <em>Journal of Allergy and Clinical Immunology</em>.<br ><br ></li><li style="text-align:justify;">On November 13, 2020, the company presented data in several abstracts at the 2020 Annual Scientific Meeting of the American College of Allergy, Asthma &amp; Immunology across HAE patients, caregivers and treating physicians showing many patients experience a significant treatment burden associated with current prophylactic HAE therapies.<br ><br ></li><li>On November 30, 2020, the company announced that the journal <em>Allergy</em> had published data from the APeX-J trial, a randomized, placebo-controlled trial conducted in Japan evaluating ORLADEYO for the prophylactic treatment of HAE.<br ></li></ul> </li></ul>  <p align="justify"><strong><em>Complement Oral Factor D Inhibitor Program &#8211; BCX9930</em></strong></p>  <ul type="disc"><li style="text-align:justify;">The company has completed the enrollment of its ongoing dose ranging trial in treatment-na&#239;ve (no prior treatment with C5 inhibitors) paroxysmal nocturnal hemoglobinuria (PNH) patients, and PNH patients with an inadequate response to C5 inhibitors. The company plans to present data from the 16 enrolled PNH patients (10 treatment na&#239;ve and six inadequate C5 responders) at its upcoming R&amp;D day on March 22.<br ><br ></li><li style="text-align:justify;">In previously reported data from treatment-na&#239;ve (no prior treatment with C5 inhibitors) PNH patients receiving doses of oral BCX9930 through 400 mg bid, oral BCX9930 drove rapid and dose-dependent reductions in key biomarkers, including LDH, and increasing hemoglobin levels in all PNH patients in the trial. Increases in hemoglobin levels were maintained without transfusions. BCX9930 has been safe and well tolerated at all doses in the trial. No drug-related serious adverse events have been reported.<br ></li></ul>  <p align="justify"><strong><em>Additional Updates</em></strong></p>  <ul type="disc"><li style="text-align:justify;">On December 7, 2020, the company announced transactions totaling $325 million in funding for BioCryst, with $250 million available at closing, to support the launch of ORLADEYO in HAE and the development of BCX9930. Royalty Pharma provided BioCryst with an upfront cash payment of $125 million and will receive royalties on direct annual net sales of ORLADEYO up to $550 million, and a tiered percentage of sublicense revenue for ORLADEYO in certain territories. In addition, Royalty Pharma will receive a 1.0% royalty on global net sales of BCX9930, if approved. A fund managed by Athyrium Capital Management provided BioCryst with a $200 million credit facility, of which BioCryst drew $125 million at closing. The additional capital will be available in two tranches at BioCryst&#8217;s option, upon reaching defined revenue milestones. The credit facility bears interest at LIBOR + 8.25% (with a LIBOR floor of 1.75%) and is interest-only for the entire five-year term, with all outstanding principal due at maturity. <br ><br ></li><li style="text-align:justify;">On December 21, 2020, the company announced that in a Phase 1 clinical trial with BCX9250, an oral activin receptor-like kinase-2 (ALK-2) inhibitor discovered and developed by BioCryst for the treatment of fibrodysplasia ossificans progressiva, BCX9250 was safe and well tolerated at all doses studied, with linear and dose-proportional exposure supporting once-daily dosing.<br ><br ></li><li style="text-align:justify;">On February 3, 2021, the company announced that the FDA had approved a supplemental new drug application for RAPIVAB<sup>&#174;</sup> (peramivir injection) expanding the patient population of RAPIVAB for the treatment of acute uncomplicated influenza to include patients six months and older who have been symptomatic for no more than two days. Prior to this approval, RAPIVAB had been indicated for patients two years and older.<br ></li></ul>  <p align="justify"><strong>Fourth Quarter 2020 Financial Results </strong></p>  <p align="justify">For the three months ended December 31, 2020, total revenues were $4.0 million, compared to $39.7 million in the fourth quarter of 2019. In the fourth quarter of 2019, we recognized revenue of $20.1 related to a one-time upfront milestone per the Torii agreement. Additionally, in that period we recognized $13.9 million of RAPIVAB product sales under our U.S. Department of Health and Human Services (HHS) contract, while in the fourth quarter 2020 we had no RAPIVAB product sales under our HHS contract. ORLADEYO revenues in the fourth quarter of 2020 were $0.1 million.</p>  <p align="justify">Research and development (R&amp;D) expenses for the fourth quarter of 2020 increased to $35.4 million from $26.8&#160;million in the fourth quarter of 2019, primarily due to increased investment in our Factor D and galidesivir programs, partially offset by a ramp down of clinical investment related to ORLADEYO, which launched commercially in the U.S. during December 2020.</p>  <p align="justify">Selling, general and administrative (SG&amp;A) expenses for the fourth quarter of 2020 increased to $21.0 million, compared to $10.5&#160;million in the fourth quarter of 2019. The increase was primarily due to increased investment in commercial activities to support the U.S. launch of ORLADEYO.</p>  <p align="justify">Interest expense was $5.6 million in the fourth quarter of 2020, compared to $3.1&#160;million in the fourth quarter of 2019. This increase was due to service on the royalty and debt financings which were completed in December 2020. As part of those financings, there was also a loss on debt extinguishing related to the closing of our secured credit facility with MidCap Financial.</p>  <p align="justify">Net loss for the fourth quarter of 2020 was $60.5&#160;million, or $0.34 per share, compared to a net loss of $2.6 million, or $0.02 per share, for the fourth quarter of 2019. <br >&#160;&#160; <br >Cash, cash equivalents, restricted cash and investments totaled $302.6 million at December 31, 2020, and reflect an increase from $137.8 million at December 31, 2019. Cash, cash equivalents, restricted cash and investments include $250 million in cash received through transactions with Royalty Pharma and Athyrium Capital Management in December 2020. Operating cash use for the fourth quarter of 2020 was $49.9 million, and for the full year of 2020 was $147.9 million.</p>  <p align="justify"><strong>Full Year 2020 Financial Results </strong></p>  <p align="justify">For the full year ended December 31, 2020, total revenues were $17.8 million, compared to $48.8 million in the full year ended December 31, 2019. In the fourth quarter of 2019 we recognized revenue of $20.1 related to a one-time upfront milestone per the Torii agreement, with the remaining amount of $1.9 million recognized in 2020. Additionally, in the fourth quarter of 2019 we recognized $13.9 million of RAPIVAB product sales under our HHS contract, while in the fourth quarter 2020 we had no RAPIVAB product sales under our HHS contract.</p>  <p align="justify">R&amp;D expenses in full year 2020 increased to $123.0 million from $107.1 million in full year 2019, primarily due to increased investment in our Factor D and galidesivir programs, and an increase in other research, preclinical and development activities, partially offset by a ramp down of clinical investment related to ORLADEYO, which launched commercially in the U.S. during December 2020.</p>  <p align="justify">SG&amp;A expenses in full year 2020 increased to $67.9 million, compared to $37.1 million in full year 2019. The increase was primarily due to increased investment in commercial activities to support the U.S. launch of ORLADEYO.</p>  <p align="justify">Interest and other income was $9.4 million in full year 2020, compared to $1.9 million in full year 2019. The increase was primarily due to the settlement of arbitration proceedings related to our Seqirus dispute in the first quarter of 2020.</p>  <p align="justify">Interest expense was $14.5 million in full year 2020, compared to $11.9&#160;million in full year 2019. This was due to service on the royalty and debt financings which were completed in December 2020. As part of those financings, there was also a loss on debt extinguishing related to the closing of our secured credit facility with MidCap Financial.</p>  <p align="justify">Net loss for full year 2020 was $182.8&#160;million, or $1.09 per share, compared to a net loss of $108.9&#160;million, or $0.94 per share, for full year 2019.&#160;&#160;</p>  <p align="justify"><strong>Financial </strong><strong>Outlook for 2021</strong></p>  <p align="justify">In the launch period for ORLADEYO, the company is not providing specific revenue or operating expense guidance. Based on our expectations for revenue, operating expenses, and our option to access an additional $75 million from our existing credit facility, we believe our current cash runway takes us into 2023.&#160;&#160;</p>  <p><strong>Conference Call and Webcast </strong></p>  <p align="justify">BioCryst management will host a conference call and webcast at 8:30 a.m. ET today to discuss the financial results and provide a corporate update. The live call may be accessed by dialing 877-303-8027 for domestic callers and 760-536-5165 for international callers and using conference ID # 6779206. A live webcast of the call and any slides will be available online at the investors section of the company website at www.biocryst.com. A telephone replay of the call will be available by dialing 855-859-2056 for domestic callers or 404-537-3406 for international callers and entering the conference ID # 6779206.</p>  <p align="justify"><strong>About BioCryst Pharmaceuticals </strong></p>  <p align="justify">BioCryst Pharmaceuticals discovers novel, oral, small-molecule medicines that treat rare diseases in which significant unmet medical needs exist and an enzyme plays a key role in the biological pathway of the disease. Oral, once-daily ORLADEYO&#153; (berotralstat) is approved in the United States and Japan for the prevention of HAE attacks in adults and pediatric patients 12 years and older, and under regulatory review for approval in the European Union. BioCryst has several ongoing development programs including BCX9930, an oral Factor D inhibitor for the treatment of complement-mediated diseases, BCX9250, an ALK-2 inhibitor for the treatment of fibrodysplasia ossificans progressiva, and galidesivir, a potential treatment for Marburg virus disease and Yellow Fever. RAPIVAB<sup>&#174;</sup> (peramivir injection), a viral neuraminidase inhibitor for the treatment of influenza, has received regulatory approval in the U.S., Canada, Australia, Japan, Taiwan and Korea. Post-marketing commitments for RAPIVAB are ongoing. For more information, please visit the company&#8217;s website at www.biocryst.com.</p>  <p><strong>Forward-Looking Statements </strong></p>  <p align="justify">This press release contains forward-looking statements, including statements regarding future results, performance or achievements. These statements involve known and unknown risks, uncertainties and other factors which may cause BioCryst&#8217;s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These statements reflect our current views with respect to future events and are based on assumptions and are subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Some of the factors that could affect the forward-looking statements contained herein include: the ongoing COVID-19 pandemic, which could create challenges in all aspects of BioCryst&#8217;s business, including without limitation, delays, stoppages, difficulties and increased expenses with respect to BioCryst&#8217;s and its partners&#8217; development, regulatory processes and supply chains, negatively impact BioCryst&#8217;s ability to access the capital or credit markets to finance its operations, or have the effect of heightening many of the risks described below or in the documents BioCryst files periodically with the Securities and Exchange Commission; BioCryst&#8217;s ability to successfully implement its commercialization plans for, and to commercialize ORLADEYO, which could take longer or may be more expensive than planned; the results of BioCryst&#8217;s partnerships with Torii and OrphanPacific may not meet BioCryst&#8217;s current expectations; risks related to government actions, including that decisions and other actions relating to pricing and exclusivity of ORLADEYO in Japan may not be taken when expected or at all, or that the outcomes of such decisions and other actions may not be in line with BioCryst&#8217;s current expectations; the commercial viability of ORLADEYO, including its ability to achieve market acceptance, which could also impact the amount of any related royalties BioCryst would be entitled to receive from Torii; ongoing and future preclinical and clinical development of BCX9930, BCX9250 and galidesivir may not have positive results; BioCryst may not be able to enroll the required number of subjects in planned clinical trials of product candidates; BioCryst may not advance human clinical trials with product candidates as expected; the FDA, EMA, PMDA or other applicable regulatory agency may require additional studies beyond the studies planned for products and product candidates, may not provide regulatory clearances which may result in delay of planned clinical trials, may impose certain restrictions, warnings, or other requirements on products and product candidates, may impose a clinical hold with respect to product candidates, or may withhold, delay or withdraw market approval for products and product candidates; product candidates, if approved, may not achieve market acceptance; BioCryst&#8217;s ability to successfully manage its growth and compete effectively; risks related to the international expansion of BioCryst&#8217;s business; and actual financial results may not be consistent with expectations, including that operating expenses and cash usage may not be within management's expected ranges.&#160; Please refer to the documents BioCryst files periodically with the Securities and Exchange Commission, specifically BioCryst&#8217;s most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K, all of which identify important factors that could cause the actual results to differ materially from those contained in BioCryst&#8217;s projections and forward-looking statements.</p>  <p align="justify"><strong><u>Investors:</u></strong><br >John Bluth<br >+1 919 859 7910<br >jbluth@biocryst.com</p>  <p align="justify"><strong><u>Media:</u></strong><br >Catherine Collier Kyroulis<br >+1 917 886 5586<br >ckyroulis@biocryst.com</p>  <p align="justify">BCRXW</p> <table style="width:100%; border-collapse:collapse !important;;border-collapse: collapse; "><tr><td colspan="16" style="max-width:40%; min-width:40%;;text-align: center ;  vertical-align: middle; ">&#160;</td></tr><tr><td colspan="16" style="max-width:40%; min-width:40%;;text-align: center ;  vertical-align: middle; "><strong>BIOCRYST PHARMACEUTICALS, INC.</strong><strong><br ></strong></td></tr><tr><td colspan="16" style="text-align: center ;  vertical-align: middle; "><strong>CONSOLIDATED FINANCIAL SUMMARY</strong><strong><br ></strong></td></tr><tr><td colspan="16" style="text-align: center ;  vertical-align: middle; ">(in thousands, except per share)<br ></td></tr><tr><td style="max-width:37%; width:37%; min-width:37%;;text-align: center ;  vertical-align: middle; ">&#160;</td><td style="max-width:1%; width:1%; min-width:1%;;text-align: center ;  vertical-align: middle; ">&#160;</td><td style="max-width:13%; width:13%; min-width:13%;;text-align: center ;  vertical-align: middle; ">&#160;</td><td style="max-width:1%; width:1%; min-width:1%;;text-align: center ;  vertical-align: middle; ">&#160;</td><td class="hugin" style="max-width:1%; width:1%; min-width:1%;">&#160;</td><td style="max-width:1%; width:1%; min-width:1%;;text-align: center ;  vertical-align: middle; ">&#160;</td><td style="max-width:13%; width:13%; min-width:13%;;text-align: center ;  vertical-align: middle; ">&#160;</td><td style="max-width:1%; width:1%; min-width:1%;;text-align: center ;  vertical-align: middle; ">&#160;</td><td class="hugin" style="max-width:1%; width:1%; min-width:1%;">&#160;</td><td style="max-width:1%; width:1%; min-width:1%;;text-align: center ;  vertical-align: middle; ">&#160;</td><td style="max-width:13%; width:13%; min-width:13%;;text-align: center ;  vertical-align: middle; ">&#160;</td><td style="max-width:1%; width:1%; min-width:1%;;text-align: center ;  vertical-align: middle; ">&#160;</td><td class="hugin" style="max-width:1%; width:1%; min-width:1%;">&#160;</td><td style="max-width:1%; width:1%; min-width:1%;;text-align: center ;  vertical-align: middle; ">&#160;</td><td style="max-width:13%; width:13%; min-width:13%;;text-align: right ;  vertical-align: middle; ">&#160;</td><td style="max-width:1%; width:1%; min-width:1%;;text-align: right ;  vertical-align: middle; ">&#160;</td></tr><tr><td style="text-align: left ;  vertical-align: middle; "><strong>Statements of Operations</strong> (Unaudited)</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td></tr><tr><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td></tr><tr><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td colspan="6" style="text-align: center ;  vertical-align: middle; ">Three Months Ended<br ></td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td colspan="6" style="text-align: center ;  vertical-align: middle; ">Twelve Months Ended<br ></td></tr><tr><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td colspan="6" style="text-align: center ;  vertical-align: middle; ">December 31,<br ></td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td colspan="6" style="text-align: center ;  vertical-align: middle; ">December 31,<br ></td></tr><tr><td style="text-align: center ;  vertical-align: middle; ">&#160;</td><td style="text-align: center ;  vertical-align: middle; ">&#160;</td><td colspan="2" style="border-bottom: solid black 1pt ; padding-left: 0 ; padding-right: 0 ; text-align: center ;  vertical-align: middle; ">2020</td><td style="text-align: center ;  vertical-align: middle; ">&#160;</td><td style="border-bottom: solid black 1pt ; ">&#160;</td><td colspan="2" style="border-bottom: solid black 1pt ; padding-right: 0 ; text-align: center ;  vertical-align: middle; ">2019</td><td style="text-align: center ;  vertical-align: middle; ">&#160;</td><td style="text-align: center ;  vertical-align: middle; ">&#160;</td><td colspan="2" style="border-bottom: solid black 1pt ; padding-left: 0 ; padding-right: 0 ; text-align: center ;  vertical-align: middle; ">2020</td><td style="text-align: center ;  vertical-align: middle; ">&#160;</td><td style="border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; ">&#160;</td><td colspan="2" style="border-bottom: solid black 1pt ; padding-right: 0 ; text-align: center ;  vertical-align: middle; ">2019</td></tr><tr><td style="text-align: left ;  vertical-align: middle; ">Revenues:</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td></tr><tr><td style="vertical-align: middle;   text-align: left;   padding-left: 10.0px; ">Product sales</td><td style="text-align: right ;  vertical-align: middle; ">$</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">605</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">$</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">15,519</td><td style="padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">$</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">3,301</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">$</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">17,533</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">&#160;</td></tr><tr><td style="vertical-align: middle;   text-align: left;   padding-left: 10.0px; ">Royalty revenue</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">1,138</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">2,777</td><td style="padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">3,381</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">6,303</td><td style="padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td></tr><tr><td style="text-align: left ;  vertical-align: middle; ">Collaborative and other research and development</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="border-bottom: solid black 1pt ; padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">2,273</td><td style="border-bottom: solid black 1pt ; padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="border-bottom: solid black 1pt ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">21,429</td><td style="border-bottom: solid black 1pt ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="border-bottom: solid black 1pt ; padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">11,130</td><td style="border-bottom: solid black 1pt ; padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="border-bottom: solid black 1pt ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">24,999</td><td style="border-bottom: solid black 1pt ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td></tr><tr><td style="text-align: left ;  vertical-align: middle; ">Total revenues</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">4,016</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">39,725</td><td style="padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">17,812</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">48,835</td><td style="padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td></tr><tr><td style="vertical-align: middle;   text-align: left;   padding-left: 10.0px; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: left ;  vertical-align: middle; ">&#160;</td></tr><tr><td style="text-align: left ;  vertical-align: middle; ">Expenses:</td><td style="text-align: left ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: left ;  vertical-align: middle; ">&#160;</td></tr><tr><td style="text-align: left ;  vertical-align: middle; ">Cost of product sales</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">33</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">2,327</td><td style="padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">1,550</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">3,726</td><td style="padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td></tr><tr><td style="text-align: left ;  vertical-align: middle; ">Research and development</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">35,354</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">26,774</td><td style="padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">122,964</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">107,068</td><td style="padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td></tr><tr><td style="text-align: left ;  vertical-align: middle; ">Selling, general and administrative</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">20,986</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">10,489</td><td style="padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">67,929</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">37,121</td><td style="padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td></tr><tr><td style="vertical-align: middle;   text-align: left;   padding-left: 10.0px; ">Royalty</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="border-bottom: solid black 1pt ; padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">48</td><td style="border-bottom: solid black 1pt ; padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="border-bottom: solid black 1pt ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">244</td><td style="border-bottom: solid black 1pt ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="border-bottom: solid black 1pt ; padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">126</td><td style="border-bottom: solid black 1pt ; padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="border-bottom: solid black 1pt ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">375</td><td style="border-bottom: solid black 1pt ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td></tr><tr><td style="text-align: left ;  vertical-align: middle; ">Total operating expenses</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="border-bottom: solid black 1pt ; padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">56,421</td><td style="border-bottom: solid black 1pt ; padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="border-bottom: solid black 1pt ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">39,834</td><td style="border-bottom: solid black 1pt ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="border-bottom: solid black 1pt ; padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">192,569</td><td style="border-bottom: solid black 1pt ; padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="border-bottom: solid black 1pt ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">148,290</td><td style="border-bottom: solid black 1pt ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td></tr><tr><td style="vertical-align: middle;   text-align: left;   padding-left: 10.0px; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: left ;  vertical-align: middle; ">&#160;</td></tr><tr><td style="text-align: left ;  vertical-align: middle; ">Loss from operations</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">(52,405</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">)</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">(109</td><td style="padding-right: 0 ; text-align: left ;  vertical-align: middle; ">)</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">(174,757</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">)</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">(99,455</td><td style="padding-right: 0 ; text-align: left ;  vertical-align: middle; ">)</td></tr><tr><td style="vertical-align: middle;   text-align: left;   padding-left: 10.0px; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: left ;  vertical-align: middle; ">&#160;</td></tr><tr><td style="text-align: left ;  vertical-align: middle; ">Interest and other income</td><td class="hugin">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">528</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">388</td><td style="padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">9,420</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">1,933</td><td style="padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td></tr><tr><td style="text-align: left ;  vertical-align: middle; ">Interest expense</td><td class="hugin">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">(5,609</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">)</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">(3,087</td><td style="padding-right: 0 ; text-align: left ;  vertical-align: middle; ">)</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">(14,501</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">)</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">(11,892</td><td style="padding-right: 0 ; text-align: left ;  vertical-align: middle; ">)</td></tr><tr><td style="text-align: left ;  vertical-align: middle; ">Loss on debt extinguishment</td><td class="hugin">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">(2,011</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">)</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">-</td><td style="padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">(2,011</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">)</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">-</td><td style="padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td></tr><tr><td style="text-align: left ;  vertical-align: middle; ">(Loss) gain on foreign currency</td><td class="hugin">&#160;</td><td style="border-bottom: solid black 1pt ; padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">(996</td><td style="border-bottom: solid black 1pt ; padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">)</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="border-bottom: solid black 1pt ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">186</td><td style="border-bottom: solid black 1pt ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td style="border-bottom: solid black 1pt ; padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">(965</td><td style="border-bottom: solid black 1pt ; padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">)</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="border-bottom: solid black 1pt ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">517</td><td style="border-bottom: solid black 1pt ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td></tr><tr><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: left ;  vertical-align: middle; ">&#160;</td></tr><tr><td style="text-align: left ;  vertical-align: middle; ">Net loss</td><td style="text-align: right ;  vertical-align: middle; ">$</td><td style="border-bottom: double black 3pt ; padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">(60,493</td><td style="border-bottom: double black 3pt ; padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">)</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">$</td><td style="border-bottom: double black 3pt ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">(2,622</td><td style="border-bottom: double black 3pt ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">)</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">$</td><td style="border-bottom: double black 3pt ; padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">(182,814</td><td style="border-bottom: double black 3pt ; padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">)</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">$</td><td style="border-bottom: double black 3pt ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">(108,897</td><td style="border-bottom: double black 3pt ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">)</td></tr><tr><td style="vertical-align: middle;   text-align: left;   padding-left: 10.0px; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: left ;  vertical-align: middle; ">&#160;</td></tr><tr><td style="text-align: left ;  vertical-align: middle; ">Basic and diluted net loss per common share</td><td style="text-align: right ;  vertical-align: middle; ">$</td><td style="border-bottom: double black 3pt ; padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">(0.34</td><td style="border-bottom: double black 3pt ; padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">)</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">$</td><td style="border-bottom: double black 3pt ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">(0.02</td><td style="border-bottom: double black 3pt ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">)</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">$</td><td style="border-bottom: double black 3pt ; padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">(1.09</td><td style="border-bottom: double black 3pt ; padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">)</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">$</td><td style="border-bottom: double black 3pt ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">(0.94</td><td style="border-bottom: double black 3pt ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">)</td></tr><tr><td style="text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: left ;  vertical-align: middle; ">&#160;</td></tr><tr><td style="text-align: left ;  vertical-align: middle; ">Weighted average shares outstanding</td><td class="hugin">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">176,618</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">131,303</td><td style="padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">167,267</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">115,600</td><td style="padding-right: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td></tr></table> <p><br ></p>  <p>&#160;<br ></p> <table style="width:100%; border-collapse:collapse !important;;border-collapse: collapse; "><tr><td style="max-width:37%; width:37%; min-width:37%;;vertical-align: middle;   text-align: left;   padding-left: 20.0px; border-top: solid black 1pt ; ">&#160;</td><td style="max-width:6%; width:6%; min-width:6%;;border-top: solid black 1pt ; ">&#160;</td><td style="max-width:19%; width:19%; min-width:19%;;border-top: solid black 1pt ; ">&#160;</td><td style="max-width:6%; width:6%; min-width:6%;;border-top: solid black 1pt ; ">&#160;</td><td style="max-width:1%; width:1%; min-width:1%;;border-top: solid black 1pt ; ">&#160;</td><td style="max-width:6%; width:6%; min-width:6%;;border-top: solid black 1pt ; ">&#160;</td><td style="max-width:19%; width:19%; min-width:19%;;border-top: solid black 1pt ; ">&#160;</td><td style="max-width:6%; width:6%; min-width:6%;;border-top: solid black 1pt ; ">&#160;</td></tr><tr><td style="text-align: left ;  vertical-align: middle; "><strong>Balance Sheet Data</strong> (in thousands)</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td></tr><tr><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="text-align: center ;  vertical-align: middle; ">December 31, 2020</td><td style="text-align: center ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td style="text-align: center ;  vertical-align: middle; ">December 31, 2019</td><td style="text-align: center ;  vertical-align: middle; ">&#160;</td></tr><tr><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td style="border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; ">(Unaudited)</td><td style="border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; ">&#160;</td><td class="hugin">&#160;</td><td class="hugin">&#160;</td><td style="border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; ">(Note 1)</td><td style="border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; ">&#160;</td></tr><tr><td style="text-align: left ;  vertical-align: middle; ">Cash, cash equivalents and investments</td><td style="border-top: solid black 1pt ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">$</td><td style="border-top: solid black 1pt ; padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">300,366</td><td style="border-top: solid black 1pt ; padding-left: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="border-top: solid black 1pt ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">$</td><td style="border-top: solid black 1pt ; padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">136,226</td><td style="border-top: solid black 1pt ; padding-left: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td></tr><tr><td style="text-align: left ;  vertical-align: middle; ">Restricted cash</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">2,221</td><td style="padding-left: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">1,551</td><td style="padding-left: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td></tr><tr><td style="text-align: left ;  vertical-align: middle; ">Receivables</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">8,646</td><td style="padding-left: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">22,146</td><td style="padding-left: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td></tr><tr><td style="text-align: left ;  vertical-align: middle; ">Total assets</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">334,715</td><td style="padding-left: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">175,282</td><td style="padding-left: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td></tr><tr><td style="text-align: left ;  vertical-align: middle; ">Non-recourse notes payable</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">30,000</td><td style="padding-left: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">29,561</td><td style="padding-left: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td></tr><tr><td style="text-align: left ;  vertical-align: middle; ">Senior credit facility</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">-</td><td style="padding-left: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">50,309</td><td style="padding-left: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td></tr><tr><td style="text-align: left ;  vertical-align: middle; ">Secured term loan</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">119,735</td><td style="padding-left: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">-</td><td style="padding-left: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td></tr><tr><td style="text-align: left ;  vertical-align: middle; ">Royalty financing obligation</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">124,717</td><td style="padding-left: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">-</td><td style="padding-left: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td></tr><tr><td style="text-align: left ;  vertical-align: middle; ">Accumulated deficit</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">(1,023,442</td><td style="padding-left: 0 ; text-align: left ;  vertical-align: middle; ">)</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">(840,628</td><td style="padding-left: 0 ; text-align: left ;  vertical-align: middle; ">)</td></tr><tr><td style="text-align: left ;  vertical-align: middle; ">Stockholders&#8217; (deficit) equity</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">(19,262</td><td style="padding-left: 0 ; text-align: left ;  vertical-align: middle; ">)</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">38,252</td><td style="padding-left: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td></tr><tr><td style="text-align: left ;  vertical-align: middle; ">Shares of common stock outstanding</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">176,883</td><td style="padding-left: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-right: 0 ; text-align: right ;  vertical-align: middle; ">&#160;</td><td style="padding-left: 0 ; padding-right: 0 ; text-align: right ;  vertical-align: middle; ">154,082</td><td style="padding-left: 0 ; text-align: left ;  vertical-align: middle; ">&#160;</td></tr><tr><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td><td style="text-align: right ;  vertical-align: middle; ">&#160;</td></tr><tr><td colspan="8" style="text-align: left ;  vertical-align: middle; ">Note 1: Derived from audited financial statements.&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td></tr></table> <p><strong><br ><br >U.S. Indication and Important Safety Information </strong></p>  <p align="justify"><strong>INDICATION</strong><br >ORLADEYO&#153; (berotralstat) is a plasma kallikrein inhibitor indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adults and pediatric patients 12 years and older.</p>  <p align="justify"><strong>Limitations of use</strong><br >The safety and effectiveness of ORLADEYO for the treatment of acute HAE attacks have not been established. ORLADEYO should not be used for the treatment of acute HAE attacks. Additional doses or dosages of ORLADEYO higher than 150 mg once daily are not recommended due to the potential for QT prolongation.</p>  <p align="justify"><strong>IMPORTANT SAFETY INFORMATION </strong><br >An increase in QT prolongation was observed at dosages higher than the recommended 150 mg once-daily dosage and was concentration dependent.</p>  <p align="justify">The most common adverse reactions (&#8805;10% and higher than placebo) in patients receiving ORLADEYO were abdominal pain, vomiting, diarrhea, back pain, and gastroesophageal reflux disease.</p>  <p align="justify">A reduced dosage of 110 mg taken orally once daily with food is recommended in patients with moderate or severe hepatic impairment (Child-Pugh B or C) and in patients taking chronically administered P-glycoprotein (P-gp) or breast cancer resistance protein (BCRP) inhibitors (eg, cyclosporine).</p>  <p align="justify">Berotralstat is a substrate of P-gp and BCRP. P-gp inducers (eg, rifampin, St. John&#8217;s wort) may decrease berotralstat plasma concentration, leading to reduced efficacy of ORLADEYO. The use of P-gp inducers is not recommended with ORLADEYO.</p>  <p align="justify">ORLADEYO at a dose of 150 mg is a moderate inhibitor of CYP2D6 and CYP3A4. For concomitant medications with a narrow therapeutic index that are predominantly metabolized by CYP2D6 or CYP3A4, appropriate monitoring and dose titration is recommended. ORLADEYO at a dose of 300 mg is a P-gp inhibitor. Appropriate monitoring and dose titration is recommended for P-gp substrates (eg, digoxin) when coadministering with ORLADEYO.</p>  <p align="justify">The safety and effectiveness of ORLADEYO in pediatric patients &lt;12 years of age have not been established.</p>  <p align="justify">There are insufficient data available to inform drug-related risks with ORLADEYO use in pregnancy. There are no data on the presence of berotralstat in human milk, its effects on the breastfed infant, or its effects on milk production.</p>  <p align="justify"><strong>To report SUSPECTED ADVERSE REACTIONS, contact BioCryst Pharmaceuticals, Inc. at 1-833-633-2279 or FDA at 1-800-FDA-1088 or </strong><strong>www.fda.gov/medwatch</strong><strong>.</strong></p> </p><p ></p></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>gnw-20190101.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:gnw="http://globenewswire.com/20190101" elementFormDefault="qualified" targetNamespace="http://globenewswire.com/20190101">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://globenewswire.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="gnw-20190101_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="gnw-20190101_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="gnw-20190101_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>gnw-20190101_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://globenewswire.com/role/Cover" xlink:href="gnw-20190101.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://globenewswire.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredClassAMember" xlink:label="loc_us-gaapPreferredClassAMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredClassAMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="55" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>gnw-20190101_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassAMember_lbl" xml:lang="en-US">Common Class A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredClassAMember" xlink:label="us-gaap_PreferredClassAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredClassAMember" xlink:to="us-gaap_PreferredClassAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredClassAMember_lbl" xml:lang="en-US">Preferred Class A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>gnw-20190101_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://globenewswire.com/role/Cover" xlink:href="gnw-20190101.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://globenewswire.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredClassAMember" xlink:label="loc_us-gaapPreferredClassAMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>f8k_022521_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="gnw-20190101.xsd" xlink:type="simple"/>
    <context id="Form8K">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882796</identifier>
        </entity>
        <period>
            <startDate>2021-02-25</startDate>
            <endDate>2021-02-25</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="Form8K">0000882796</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="Form8K">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="Form8K">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="Form8K">2021-02-25</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="Form8K">BioCryst Pharmaceuticals, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="Form8K">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="Form8K">000-23186</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="Form8K">62-1413174</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="Form8K">4505 Emperor Blvd., Suite 200</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="Form8K">Durham</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="Form8K">NC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="Form8K">27703</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="Form8K">919</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="Form8K">859-1302</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="Form8K">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="Form8K">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="Form8K">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="Form8K">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="Form8K">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="Form8K">BCRX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="Form8K">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="Form8K">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139794854693224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Feb. 25, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 25,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-23186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BioCryst Pharmaceuticals, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000882796<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">62-1413174<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4505 Emperor Blvd., Suite 200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Durham<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">27703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">919<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">859-1302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BCRX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MRU*UQU_"WYW<S0WW.[?X!5!+ P04    " "\.%E2EXJ[',     3 @  "P
M %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=
MOZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'
MTD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[P
MS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T
M>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( +PX65*JQ"(6,P$
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M'EKG5LJ]AU>RY1AQ_)[E#U!+ P04    " "\.%E2)!Z;HJT   #X 0  &@
M 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4 -5"I0P5,
M75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K!LIDR^SO
M *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1UW6E\./VR
M./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6?;!/
M3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ O#A94F60>9(9 0  SP,
M !,   !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +
M77 !8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5
M!TYB'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP
M39G 8ED\C<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY84(JKA%SY'7#J>SM
M2D9#L9&)7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6&F,"J;$#(&?KT70Q32:>
M,(S/N]G\P68*R,I-"A$YL01_QYTCR=U59"-(9*:O>"&R]>S[04Y;@[Z1S>/]
M#&DWY(%B6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4
M" "\.%E2!T%-8H$   "Q    $               @ $     9&]C4')O<',O
M87!P+GAM;%!+ 0(4 Q0    ( +PX65(1HAU![@   "L"   1
M  "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( +PX65*97)PC
M$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL
M4$L! A0#%     @ O#A94E.'7\41!   T \  !@              ("!#0@
M 'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( +PX65+]^K\J
MS@$  ( %   -              "  50,  !X;"]S='EL97,N>&UL4$L! A0#
M%     @ O#A94I>*NQS     $P(   L              ( !30X  %]R96QS
M+RYR96QS4$L! A0#%     @ O#A94JK$(A8S 0  (@(   \
M ( !-@\  'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( +PX65(D'INBK0
M /@!   :              "  980  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN
M<F5L<U!+ 0(4 Q0    ( +PX65)ED'F2&0$  ,\#   3              "
M 7L1  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  ,42
!  $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="f8k_022521.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globenewswire.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="f8k_022521.htm">f8k_022521.htm</File>
    <File>exh_991.htm</File>
    <File>gnw-20190101.xsd</File>
    <File>gnw-20190101_def.xml</File>
    <File>gnw-20190101_lab.xml</File>
    <File>gnw-20190101_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "f8k_022521.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "local": [
      "gnw-20190101_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "f8k_022521.htm"
     ]
    },
    "labelLink": {
     "local": [
      "gnw-20190101_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "gnw-20190101_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "gnw-20190101.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 63,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "gnw",
   "nsuri": "http://globenewswire.com/20190101",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "f8k_022521.htm",
      "contextRef": "Form8K",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://globenewswire.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "f8k_022521.htm",
      "contextRef": "Form8K",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in CCYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class A [Member]"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Class A [Member]"
       }
      }
     },
     "localname": "PreferredClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r10": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r11": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r12": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r13": {
   "Name": "Forms 10-K, 20-F, 40-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d-1"
  },
  "r14": {
   "Name": "Forms 20-F, 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220 and 240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-13"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001171843-21-001304-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001171843-21-001304-xbrl.zip
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MIYN]+"NFU))]@"E@SD- '2/9ES'EE#K#I6@!.;*ISVPC-2S&7RQ&&E@I=%E
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MF\:KE^'1')4M]VOLB.I@]RYZ)^G'FW/AS2GO89<P=M;LVXXU/.;&)]LE_%6
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M/6F+LYGL30C/7FZIX"\KXF\NZJG?_B]02P,$%     @ O#A94@XX_UR\ @
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M3^,=J=+/CHM\4^^LU]<RK[(6 #Y!L5HL:]2<-,_W\>4:<L6&_:9V',\<RKP
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M[@)!=68_KO<R(TSX+7%A(_/"=WX=V>)BLO$#V0Z995*4X?4^TFS\>MMUV.'
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M,2YH=&U02P$"% ,4    " "\.%E2^K)5P X.  !3/   #@
M@ $N*   9CAK7S R,C4R,2YH=&U02P$"% ,4    " "\.%E2#CC_7+P"   Q
M#   $               @ %H-@  9VYW+3(P,3DP,3 Q+GAS9%!+ 0(4 Q0
M   ( +PX65+M4J2!6 @  /IE   4              "  5(Y  !G;G<M,C Q
M.3 Q,#%?9&5F+GAM;%!+ 0(4 Q0    ( +PX65)9RQJ;"@L  +&+   4
M          "  =Q!  !G;G<M,C Q.3 Q,#%?;&%B+GAM;%!+ 0(4 Q0    (
M +PX65+/B!J&E@<  )M@   4              "  1A-  !G;G<M,C Q.3 Q
@,#%?<')E+GAM;%!+!08     !@ & 'D!  #@5      !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
